Assessing the distribution of a medication in the brain is critical for the treatment of a vast range of neurological disorders, especially conditions such as Parkinson’s and Alzheimer’s diseases. To that end, scientists in the United States and Sweden are developing a method to image therapeutic antisense oligonucleotides in the brain by relying on “click chemistry,” a Nobel Prize-winning technique in which molecules are linked—clicked together—like molecular Lego blocks.
Click chemistry PET imaging tracks antisense drug distribution in the brain
Tech News
-
Highlights
Free Dark Web Monitoring Stamps the $17 Million Credentials Markets
-
Highlights
Smart buildings: What happens to our free will when tech makes choices for us?
-
Apps
Screenshots have generated new forms of storytelling, from Twitter fan fiction to desktop film
-
Highlights
Darknet markets generate millions in revenue selling stolen personal data, supply chain study finds
-
Security
Privacy violations undermine the trustworthiness of the Tim Hortons brand
-
Featured Headlines
Why Tesla’s Autopilot crashes spurred the feds to investigate driver-assist technologies – and what that means for the future of self-driving cars